The CFO's Valuation Intelligence Gap
Most CFOs can tell you what the company earned last quarter. Fewer can tell you what the company is worth—or more precisely, what multiple the market would apply to those earnings today, and why.
EBITDA multiples aren't just a function of revenue or profitability. They're driven by revenue quality, customer concentration, financial reporting sophistication, management depth, recurring revenue percentage, and operational documentation. These are inputs a CFO controls—but only if they know which ones are suppressing the multiple.
KCENAV's Valuation Optimizer and Exit Readiness diagnostics translate a company's financial and operational profile into scored, benchmarked outputs that tell a CFO exactly where the value gaps are—and what to fix first. Not as a consulting recommendation. As a scored output based on your direct inputs, benchmarked against comparable companies.
For a CFO managing a company that will eventually transact—whether through a sale, capital raise, or private equity event—this intelligence is most valuable when it's gathered 12 to 24 months before the event. That's when there's still time to remediate the findings.
What CFOs Find When They Run the Valuation Suite
The most common findings for CFOs running KCENAV's valuation-focused diagnostics:
- Financial reporting quality gaps: The Exit Readiness diagnostic consistently surfaces incomplete management information systems, inconsistent chart of accounts, or missing normalized EBITDA documentation. These items aren't visible in day-to-day operations but become major deal-risk items in due diligence.
- Customer concentration suppressing the multiple: When revenue is concentrated in a small number of customers, buyers apply a concentration discount. The Valuation Optimizer quantifies this gap and models the improvement available through diversification or contractual protections.
- Working capital normalization blind spots: Many CFOs have not formally documented a normalized working capital position. Buyers define this differently than management does, and the gap at close becomes a post-transaction dispute. The Exit Readiness diagnostic surfaces this before the transaction process begins.
- Recurring revenue percentage drift: As a company grows, the mix between recurring and transactional revenue can shift without the CFO noticing. HALO Score tracks this as a strategic asset quality metric—relevant both for valuation and for investor narrative in a capital raise.
The Diagnostics Most Relevant to CFOs
Valuation Optimizer
Maps your financial and operational profile to EBITDA multiple benchmarks. Identifies the specific inputs suppressing the multiple and models the value available through targeted improvements.
Run Valuation Optimizer →Exit Readiness
Scores the financial, operational, and documentation readiness required to execute a transaction. Surfaces due diligence gaps while there's still time to remediate them.
Run Exit Readiness →M&A Readiness
Assesses structural readiness for a transaction across legal cleanliness, organizational structure, and integration capacity—relevant for both sell-side preparation and buy-side evaluation.
Run M&A Readiness →HALO Score
The strategic health index. Scores recurring revenue quality, customer concentration, disruption risk, and asset quality in a single benchmarked output. A quarterly CFO monitoring tool.
Run HALO Score →